Tuesday, December 30, 2014 4:58:48 PM
Source: Business Wire
GNCC Capital, Inc. (OTC: GNCP) (“The Company”) clarifies its position on its Stock Repurchase Program following this morning’s Press Release.
The Company is absolutely committed to its stated Stock Repurchase Program of up to $750,000.
The Company was highlighting that it was cancelling up to 29% of its outstanding shares of Common Stock and revising existing agreements to prevent additional shares of Common Stock from entering the “Free Float”.
The statement that, “The Company’s Management believes that it is illogical to expend any sums of monies on any future stock repurchases, in the market, from either Loan Term Convertible Loan Note Holders or from any other third parties that have directly or indirectly contracted with the Company and/or its subsidiary companies.”;
Meant That:
The Company was solely interested in repurchasing shares of its Common Stock in the market from Sellers other than Loan Term Convertible Loan Note Holders or from any other third parties that have directly or indirectly contracted with the Company and/or its subsidiary companies.
My posts are my opinion and should not be used as investment advice. Make your own due diligence and decisions in your stock trades. GLTA
Lingerie Fighting Championships Signs Broadcast Deal With Maybacks Global Entertainment • BOTY • Sep 26, 2024 9:00 AM
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM